Transforming growth factor β1 genotype polymorphisms determine AV fistula patency in hemodialysis patients

Kidney International

Volumn 64, Issue 3, 2003, Pages 1101-1107

  Heine, Gunnar H ^a   Ulrich, Christof ^a   Sester, Urban ^a   Sester, Martina ^a   Köhler, Hans ^a   Girndt, Matthias ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Arteriovenous fistula; Polymorphism; Single nucleotide; Transforming growth factor beta

Indexed keywords

CYTOKINE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL OBSERVATION; DIABETES MELLITUS; DISEASE PREDISPOSITION; EXTRACELLULAR MATRIX; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SIGNAL DETECTION; STATISTICAL SIGNIFICANCE; STENOSIS; THROMBOSIS; TREATMENT FAILURE; VASCULAR ACCESS; VASCULAR PATENCY;

EID: 0042932664     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00176.x     Document Type: Article

References (43)

1. FELDMAN HI, HELD PJ, HUTCHINSON JT, et al: Hemodialysis vascular access morbidity in the United States. Kidney Int 43:1091-1096, 1993
2. FELDMAN HI, KOBRIN S, WASSERSTEIN A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 7:523-535, 1996
3. VALJI K, BOOKSTEIN JJ, ROBERTS AC, DAVIS GB: Pharmacomechanical thrombolysis and angioplasty in the management of clotted hemodialysis grafts: Early and late clinical results. Radiology 178:243-247, 1991
4. WINDUS DW: Permanent vascular access: A nephrologist's view. Am J Kidney Dis 21:457-471, 1993
5. REKHTER M, NICHOLLS S, FERGUSON M, GORDON D: Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 13:609-617, 1993
6. ROY-CHAUDHURY P, KELLY BS, MILLER MA, et al: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59:2325-2334, 2001
7. SWEDBERG SH, BROWN BG, SIGLEY R, et al: Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 80:1726-1736, 1989
8. WEISS MF, SCIVITTARO V, ANDERSON JM: Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 37:970-980, 2001
9. LEMSON MS, TORDOIR JH, DAEMEN MJ, KITSLAAR PJ: Intimal hyperplasia in vascular grafts. Fur J Vasc Endovasc Surg 19:336-350, 2000
10. AWAD MR, EL GAMEL A, HASLETON P, et al: Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66:1014-1020, 1998
11. PERREY C, PRAVICA V, SINNOTT PJ, HUTCHINSON IV: Genotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: A technical report. Transpl Immunol 6:193-197, 1998
12. PERREY C, TURNER SJ, PRAVICA V, et al: ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 7:127-128, 1999
13. NATIONAL KIDNEY FOUNDATION: K/DOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis 37:S137-S181, 2001
14. DE MARCHI S, FALLETI E, GIACOMELLO R, et al: Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 7:1169-1177, 1996
15. BLOBE GC, SCHIEMANN WP, LODISH HF: Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-1358, 2000
16. BORDER WA, NOBLE NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
17. GRAINGER DJ, KEMP PR, METCALFE JC, et al: The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1:74-79, 1995
18. 1 preserves endothelial function after multiple brief coronary artery occlusions and reperfusion. Am Heart J 127:1456-1461, 1994
19. WALTENBERGER J: Modulation of growth factor action: Implications for the treatment of cardiovascular diseases. Circulation 96:4083-4094, 1997
20. CAMBIEN F, RICARD S, TROESCH A, et al: Polymorphisms of the transforming growth factor-b1 gene in relation to myocardial infarction and blood pressure. Hypertension 28:881-887, 1996
21. LI B, KHANNA A, SHARMA V, et al: TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33:271-275, 1999
22. 1 cytokine genotype. J Allergy Clin Immunol 108:281-284, 2001
23. IKEGAYA N, YAMAMOTO T, TAKESHITA A, et al: Elevated erythropoietin receptor and transforming growth factor-beta1 expression in stenotic arteriovenous fistulae used for hemodialysis. J Am Soc Nephrol 11:928-935, 2000
24. STRACKE S, KONNER K, KOSTLIN I, et al: Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int 61:1011-1019, 2002
25. TANIGUCHI Y, YORIOKA N, YAMASHITA K, et al: Transforming growth factor-beta1 may be involved in shunt obstruction in patients on chronic hemodialysis. Nephron 81:102-105, 1999
26. BATTEGAY EJ, RAINES EW, SEIFERT RA, et al: TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 63:515-524, 1990
27. BROGI E, WU T, NAMIKI A, ISNER JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652, 1994
28. JAWIEN A, BOWEN-POPE DF, LINDNER V, et al: Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89:507-511, 1992
29. LINDNER V, REIDY MA: Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88:3739-3743, 1991
30. RUTHERFORD C, MARTIN W, SALAME M, et al: Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor. Atherosclerosis 130:45-51, 1997
31. KANZAKI T, TAMURA K, TAKAHASHI K, et al: In vivo effect of TGF-beta 1. Enhanced intimal thickening by administration of TGF-beta 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vase Biol 15:1951-1957, 1995
32. WOLF YG, RASMUSSEN LM, RUOSLAHTI E: Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest 93:1172-1178, 1994
33. STEFONI S, CIANCIOLO G, DONATI G, et al: Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int 61:324-335, 2002
34. FUKASAWA M, MATSUSHITA K, KAMIYAMA M, et al: The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis 41:637-642, 2003
35. SARAN R, DYKSTRA DM, WOLFE RA, et al: Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 40:1255-1263, 2002
36. KONNER K, HULBERT-SHEARON TE, ROYS EC, PORT FK: Tailoring the initial vascular access for dialysis patients. Kidney Int 62:329-338, 2002
37. GOLLEDGE J, SMITH CJ, EMERY J, et al: Outcome of primary radiocephalic fistula for haemodialysis. Br J Surg 86:211-216, 1999
38. LEAPMAN SB, BOYLE M, PESCOVITZ MD, et al: The arteriovenous fistula for hemodialysis access: Gold standard or archaic relic? Am Surg 62:652-656, 1996
39. WINDUS DW, JENDRISAK MD, DELMEZ JA: Prosthetic fistula survival and complications in hemodialysis patients: Effects of diabetes and age. Am J Kidney Dis 19;448-452, 1992
40. MANNS BJ, BURGESS ED, PARSONS HG, et al: Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients. Kidney Int 55:315-320, 1999
41. DIXON BS, NOVAK L, FANGMAN J: Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula. Am J Kidney Dis 39:92-101, 2002
42. SREEDHARA R, HIMMELFARB J, LAZARUS M, HAKIM R: Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study. Kidney Int 45:1477-1483, 1994
43. TAMAI H, KATOH K, YAMAGUCHI T, et al: The impact of tranilast on restenosis after coronary angioplasty: The Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2). Am Heart J 143:506-513, 2002